Single-cell Omics Market Size & Share, by Product (Proteomics, Metabolomics, Transcriptomics); Application (Immunology, Neurology, Oncology, Cell Biology); End-user (Pharmaceutical & Biotechnology Companies, Research Organization, Hospitals) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 5060
  • Published Date: Jun 22, 2023
  • Report Format: PDF, PPT

Companies Dominating the Single-cell Omics Market

top-features-companies
    • Ultima Genomics, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • 10x Genomics, Inc.
    • Becton, Dickinson and Company (BD)
    • CELLENION
    • PerkinElmer Inc.
    • ANGLE plc
    • Illumina, Inc.
    • Bio-Rad Laboratories, Inc.
    • Mission Bio, Inc.
    • Standard BioTools Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Ultima Genomics, Inc. announced the partnership with 10x Genomics. With this collaboration, the ultra-high throughput sequencing systems will be using chromium single-cell gene expression solutions of 10X Genomics. Both organizations will give researchers optimized, cost-effective methods to enable larger-scale gene expression analysis in single cells.
  • Mission Bio, Inc. collaborated with Fulent Genetics. By the help of Mission Bio, Fulgent Genetics will be able to offer Pharma drug developers single-cell multi-omics for biomarker identification, clinical research, and single-cell MRD creation at large scale

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5060
  • Published Date: Jun 22, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing incidences of cancer, rising investment in cell therapy, and technological advancement of single-cell techniques are the major factors driving the market growth.

The market size of single-cell omics is anticipated to attain a CAGR of around 22% over the forecast period, i.e., 2023 – 2035.

The major players in the market are 10x Genomics, Inc., Becton, Dickinson and Company (BD), CELLENION, PerkinElmer Inc., ANGLE plc, Illumina, Inc., Bio-Rad Laboratories, Inc., Mission Bio Inc., Standard BioTools Inc. and Ultima Genomics, Inc.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by application, product, end user, and by region.

The oncology segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

There is no standardization and the higher cost of single-cell omics is estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying